Personalized Medicine and Daptomycin
The shift toward personalized medicine is influencing the Daptomycin Market by promoting tailored antibiotic therapies. Advances in genomic and diagnostic technologies enable healthcare providers to identify specific bacterial strains and resistance patterns, allowing precise selection of antibiotics like daptomycin.
Personalized treatment reduces unnecessary exposure to broad-spectrum antibiotics, minimizing side effects and resistance development. Integrating personalized approaches with daptomycin therapy enhances efficacy and patient outcomes, making it a critical component of modern infectious disease management. This trend is anticipated to accelerate market growth.